Kine Nobels SRL
Kine Nobels reported total assets of 219,306 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Aug 2026).
By total assets for 2025, Kine Nobels ranks among the 2,000 largest of the 5,000 companies in its sector (NACE 8695) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Kine Nobels shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +171 % Total assets +124 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Kine Nobels's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 28 Sep 2024
Kine Nobels's financial analysis
- Solvency82.6%sector median: 61.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Kine Nobels
Kine Nobels's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0800.867.632
- VAT number
- BE0800867632
- Peppol
- Registered · 0208:0800867632 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Apr 2023
- Registered office
- 9200 Dendermonde
- Latest accounts
- 2025 · filed on 18 Aug 2026
- Activity
- Physical therapy activities (NACE 86951)
Kine Nobels (SRL) has been based in Dendermonde since 2023, active in: physical therapy activities. For 2025, it reports a net profit of 62,324 € and equity of 181,252 €; its revenue is not published. Its solvency stands at 82.6%, above the median of its sector (61.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Kine Nobels
Companies in the same business, of comparable size and area, outside its group.
- Bert Cooreman Physiotherapy activities Dendermonde · balance sheet 221,841 €
- Ruth Danielle Physiotherapy activities Bassenge · balance sheet 219,902 €
- Kinemove Physiotherapy activities Tubize · balance sheet 216,657 €
- Elkim Physiotherapy activities Hasselt · balance sheet 216,537 €
- Stay Strong Physiotherapy activities Uccle · balance sheet 222,569 €
- Two Move Physiotherapy activities Hasselt · balance sheet 222,877 €
- Comfort Motion Podologie Physiotherapy activities Lochristi · balance sheet 215,711 €
- DELBROUCK Eric Physiotherapy activities Saint-Georges-sur-Meuse · balance sheet 215,670 €
Frequently asked questions about Kine Nobels
What is the revenue of Kine Nobels?
Kine Nobels files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Kine Nobels?
In Belgium, the VAT number is the company number prefixed with BE: BE0800867632 for Kine Nobels, if the company is VAT-registered. Its company number (CBE) is 0800.867.632.
Where is the registered office of Kine Nobels?
According to the CBE register, the registered office of Kine Nobels is in 9200 Dendermonde.
What is the equity of Kine Nobels?
At the close of the 2025 financial year, the equity of Kine Nobels amounts to 181,252 €, a solvency of 82.6% of total assets.
Who manages Kine Nobels?
The register lists 1 active mandates at Kine Nobels. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Kine Nobels within its sector?
By total assets for 2025, Kine Nobels ranks among the 2,000 largest of the 5,000 companies in its sector (NACE 8695) in Belgium that filed accounts for that financial year.
The full file of Kine Nobels
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →